Addressing pharmacogenetics in routine NGS workflows
WEBINAR DETAILS
About
At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. Today, our partners share how the analytical technology and dedicated features in the SOPHiA DDM™️ Platform have enabled the accurate detection and streamlined assessment of variants associated with Rare Diseases and Pharmacogenomics.
Discover how the SOPHiA DDM™️ Platform seamlessly integrated into routine NGS workflows for pharmacogenetic analysis.
This talk took place at on June 11th in Glasgow, UK at the European Society of Human Genetics (ESHG) Conference 2023.
Molecular Biologist at Result Laboratorium, Dordrecht, Netherlands
After my PhD at the department for Molecular Biology in Nijmegen, I continued my career as an application specialist genomics (NGS). During this work I got really enthusiastic about the field of molecular diagnostics. After a nice postdoc position...
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company revolutionizing data-driven medicine and life sciences research. Their flagship product, the SOPHiA DDM™ Platform, empowers over 750 global institutions with cloud-based analytics and insights from diverse diagnostic datasets.